MASTERINVEST Kapitalanlage GmbH Acquires Shares of 28,070 Colgate-Palmolive Company $CL

MASTERINVEST Kapitalanlage GmbH purchased a new stake in Colgate-Palmolive Company (NYSE:CL) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 28,070 shares of the company’s stock, valued at approximately $2,552,000.

A number of other large investors have also recently bought and sold shares of CL. Cidel Asset Management Inc. increased its holdings in shares of Colgate-Palmolive by 13.6% during the second quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock worth $29,912,000 after buying an additional 39,413 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of Colgate-Palmolive by 18.6% during the second quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock valued at $2,752,000 after purchasing an additional 4,738 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Colgate-Palmolive by 1.2% during the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock worth $7,522,129,000 after purchasing an additional 993,432 shares during the last quarter. Welch Group LLC increased its stake in shares of Colgate-Palmolive by 1.5% in the second quarter. Welch Group LLC now owns 665,041 shares of the company’s stock valued at $60,452,000 after buying an additional 9,689 shares during the period. Finally, Arista Wealth Management LLC bought a new position in Colgate-Palmolive in the 2nd quarter valued at approximately $571,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $78.32 on Friday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The firm has a market capitalization of $63.13 billion, a P/E ratio of 21.94, a P/E/G ratio of 5.58 and a beta of 0.30. The firm’s 50-day moving average price is $78.23 and its 200-day moving average price is $83.53. The company has a current ratio of 0.93, a quick ratio of 0.60 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. During the same quarter in the previous year, the company posted $0.91 earnings per share. The company’s quarterly revenue was up 1.9% on a year-over-year basis. Equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be paid a $0.52 dividend. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio is presently 58.26%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating on the stock in a research note on Monday, November 3rd. Bank of America decreased their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Royal Bank Of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research note on Tuesday. Citigroup lowered their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a report on Monday, November 3rd. Finally, Barclays reduced their price objective on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Ten investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $89.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.